Accueil   Diary - News   All news Lyonbiopole supports its SMEs in their fundraising efforts

Lyonbiopole supports its SMEs in their fundraising efforts

 

 

 

Lyonbiopole, the healthcare cluster of the Auvergne-Rhône-Alpes region, is organizing the 11th edition of its Private Investment Day on November 29 at Boehringer Ingelheim's headquarters in Lyon Gerland. It offers an increasingly dynamic format for fruitful exchanges between innovative health companies and specialized investors. 150 participants, including about forty investors, are expected for this event, which illustrates Lyonbiopole's strong and built commitment to its members to guide them in their search for private financing and foster links with private investors.

 



A 2019 PROGRAMME THAT ENCOURAGES EXCHANGE

 

Since 2009, Lyonbiopole has been organizing this event every year to develop networking between regional start-ups & SMEs and local, national and international investors. This illustrates its commitment to SME financing issues.


Organized with the support of its partners and sponsors - Boehringer Ingelheim Animal Health, Inova Software, KPMG and ICOSA - and in collaboration with Biowin, BPIfrance, Linksium and Pulsalys, the 2019 edition offers a rich and diversified programme:

 


* Round tables on key themes:

 

  • Resilience, the key to entrepreneurial success, led by Denis Santis (ADAMAS Avocats) with the participation of Marie-Josée Bernard (Professor, EM LYON), Xavier Mesguisch (Partner, EIGHT ADVISORY), Gérard Soula (CEO, ADOCIA) and François-Henri Boissel (CEO, NOVADISCOVERY).
  • Financial analysis: defend its value and have the rating led by Claire Verschelde (ICOSA) with the participation of Christian Homsy (ex CEO, CELYAD), Thomas Kuhn (CEO, POXEL), Martial Descoutures (analyst, ODDO BHF) and Christophe Dombu (analyst, PORTZAMPARC).

 

* A pitch session where 14 member companies in fundraising will have the opportunity to present themselves to the panel of investors present.

 

3C Health, Fluoptics, Gaoma Therapeutics, Grapheal, Mablink , MagIA, Medicing, MexBrain, Molsid, Sagitta Biotech, Sibius,Therafast-Bio, Virelieve and Ynéo Pharma.

 

* A program of individual investor/entrepreneur meetings.